- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
VBI Vaccines Inc.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-26…
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for VBI Vaccines Inc.
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
Owner | Shares | Equivalence - $0.07 per share | Last Form/Filing | Last Transaction |
---|---|---|---|---|
10% Holder | ||||
- No data - | ||||
Officers/Directors Below 10% | ||||
Internal : Director
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : CEO, President
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : CFO, Head of Corp. Development
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Head Global MFG&GM-SciVac Ltd.
|
0 | $0 |
|
|
Internal : Chief Medical Officer
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Chief Commercial Officer
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Chief Scientific Officer
|
0 | $0 |
|
|
Internal : CFO and Head of BD
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of VBI Vaccines Inc.
Short
We source Fail-To-Deliver data every month, directly from the SEC.